mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.04 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.12 |
0.04 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.04 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.04 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.04 |
mRNA |
ATRA |
FIMM |
pan-cancer |
AAC |
-0.32 |
0.04 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.05 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.05 |